【DongBao东宝是哪个国家的品牌？】

通化东宝集团有限公司坐落于中国著名的“医药城”吉林省通化市西郊，集自然美丽风光、历史人文景观、民族医药宝库为一体的兴办企业最佳之地。

1984年，年仅32岁的青年企业家李一奎以他超人的胆识和非凡的魄力，创建了白山滋补品厂。

1992年12月，组建了中国通化东宝集团。其间先后兼并了数家企业，特别是在1992年兼并了集团所在地通化县二密镇恒德村，在国内首创“以企兼农”典型范例，在全国引起强烈反响。集团成立13年来，企业规模发展之猛，多元化项目经营之广，兼并国营民企数量之多，生产设备与工艺流程之先，科研队伍研究水平之高，都堪称国内企业发展之奇迹，被业内人士誉为“东宝模式”，创造了中国企业快速蓬勃发展的神话。

东宝的制药业，以拥有世界上最先进的生物制药尖端技术而备受世人瞩目。先后研制推出了“镇脑宁”，东宝肝泰片、脑血康片等一大批国家级新药和拳头产品。在生物制药领域，集团先后投入数亿元科研经费，于1998年成功研制出具有中国独立知识产权的高科技制剂药品“甘舒霖”，填补了国内空白，使中国继美国、丹麦之后成为世界上第三个能生产基因重组人胰岛素、第二个能生产甘精胰岛素的国家，该成果被587名中国工程院院士评为中国十大科技进展新闻奖。目前，投资总额为3.5亿元的国家振兴东北老工业基地重点扶持项目——东宝基因重组人胰岛素二期扩建工程正在紧张引进和安装国外先进设备，在近两年内将达产3000公斤，满足日益增长的国内和国际市场需求。东宝集团已成为世界上具有相当规模、拥有当今先进技术的人胰岛素生产基地之一。

东宝集团坚持科学发展观，积极构建和谐型企业。1994年集团在扒宝沟建立了全国第一家由企业兴建的自然保护区；1995年先后投入600余万元，修筑507米长的堤坝和拦水坝；2003年初集团通过了国家ISO14001环境管理体系认证；使集团成为“山青、水碧、天蓝”山川秀美的生态型现代化企业，做到了经济效益与生态效益互利双赢。

今天的东宝集团，在全国人大代表、集团董事长李一奎先生的带领下，乘借国家振兴东北老工业基地的春风，励精图治，只争朝夕，为打造中国民族品牌，领跑世界生物制药技术而努力拼搏，阔步前进！

英文翻译：Tonghua Dongbao Group Co., Ltd. is located in the western suburb of Tonghua City, Jilin Province, a famous "medicine city" in China. It is the best place to set up an enterprise integrating natural beautiful scenery, historical and cultural landscape, and national medicine treasure house. In 1984, Li Yikui, a 32-year-old young entrepreneur, founded Baishan tonic factory with his superhuman courage and extraordinary courage. In December 1992, China Tonghua Dongbao group was established. During this period, several enterprises were merged successively, especially Hengde village, Ermi Town, Tonghua County, where the group is located in 1992. It is the first typical example of "combining enterprise with agriculture" in China, which has aroused strong repercussions all over the country. In the past 13 years since the establishment of the group, the rapid development of the enterprise scale, the wide diversification of project management, the large number of state-owned private enterprises to be merged, the first production equipment and technological process, and the high research level of scientific research team have all been regarded as the miracle of the development of domestic enterprises, known as the "Oriental model" by the insiders, and created the myth of the rapid and vigorous development of Chinese enterprises. Dongbao's pharmaceutical industry, with the most advanced biopharmaceutical technology in the world, has attracted worldwide attention. A large number of state-level new drugs and blockbuster products, such as "zhennaoning", Dongbao Gantai tablet, Naoxuekang tablet, have been developed and launched successively. In the field of biopharmaceutical, the group has successively invested hundreds of millions of yuan in scientific research funds. In 1998, the group successfully developed "gansulin", a high-tech pharmaceutical preparation with independent intellectual property rights in China, which filled in the domestic gap. After the United States and Denmark, China has become the third country in the world that can produce recombinant human insulin and the second country that can produce insulin glargine. This achievement has been ranked 587 in China Academicians of the Chinese Academy of Engineering awarded the top ten science and technology progress News Awards. At present, the second phase expansion project of Dongbao gene recombinant human insulin, a key supporting project for revitalizing the old industrial base in Northeast China with a total investment of 350 million yuan, is urgently introducing and installing foreign advanced equipment, which will reach a production capacity of 3000 kg in recent two years, meeting the growing domestic and international market demand. Dongbao group has become one of the human insulin production bases with considerable scale and advanced technology in the world. Dongbao group adheres to the scientific concept of development and actively constructs a harmonious enterprise. In 1994, the group established the first enterprise built Nature Reserve in babaogou; in 1995, it invested more than 6 million yuan to build 507 meter long dams and dams; at the beginning of 2003, the group passed the national ISO14001 environmental management system certification; the group became an ecological modern enterprise with beautiful mountains and rivers, achieving economic and ecological benefits Mutual benefit and win-win situation. Today's Dongbao group, under the leadership of Mr. Li Yikui, deputy to the National People's Congress and chairman of the group, takes advantage of the spring breeze of the country's revitalization of the old industrial base in Northeast China, makes every effort to build a Chinese national brand and lead the world's biopharmaceutical technology, and makes great progress!

本文链接： https://www.waitui.com/brand/f89fb8898.html